Until then, retatrutide remains an investigational compound
The funding bodies had no role in the design of the study or the collection, analysis, or interpretation of data or in writing the manuscript
Research continues into non-alcoholic fatty liver disease/NASH, dyslipidaemia, insulin resistance, and cardiovascular risk reduction
these are trial protocols only, as no licensed dosing schedules or UK SmPCs exist for either agent
While not officially approved for fatty liver disease in individuals without these conditions, some doctors prescribe semaglutide off-label for patients with NAFLD or NASH, particularly if they are at high risk of liver complications, explains Dr
Sleep, Stress, or Other Meds Are Fighting the Drug Four nights of 5-hour sleep can drop insulin sensitivity by 20 % and raise ghrelin, the hunger hormone (Spiegel et al., Lancet 1999)